Balancing optimism versus potential risks of AI-driven drug discovery
1. There is much optimism, to understate the $3.8B investment in 2025 by venture capital [1], regarding the “revolution” in AI-driven drug discovery. A 2025 report from the McKinsey Global Institut...
Authors
- Jonathan D. Hirst (ORCID: https://orcid.org/0000-0002-2726-0983)
Institutions
- University of Nottingham (GB)
Publication Details
- Journal
- Expert Opinion on Drug Discovery
- Published
- 2026-06-18
- DOI
- https://doi.org/10.1080/17460441.2026.2691836
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00